New PR shop to offer nimble alternatives

Share this article:
Hoping to address PR needs in light of shrinking budgets, Shannon Troughton has launched VoxPop Public Relations, in Indianapolis.

Troughton, who was most recently VP of corporate communications at US-based health insurer WellPoint, said the time was right for a smaller, more agile offering in the healthcare and technology PR sector.

“Companies can't afford to pay $400,000 retainers monthly or even annually to get the same experience that I have, with no overhead,” said Troughton, who has served as director of communications for GE Healthcare, and VP of corporate and public affairs at Fleishman-Hillard. 

VoxPop has already secured clients such as dLife, the online diabetes community, MDdatacor, a clinical patient data provider, and Alaven Healthcare, an Atlanta-based specialty company focused on women's health, gastroenterology and anemia.

VoxPop hopes to attract healthcare and pharma clients that have a unique technology to offer, specifically, notes Troughton, clients that “know how to talk to investors and shareholders, but need help with publicity,” she says. She began her career as a communications staffer for the late Missouri governor, Mel Carnahan. 
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?